pembrolizumab
merck
['kn040']
# kn040 long term 6 yr survival data continues to favor anti pd1 over chemo especially in pdl1 positive disease; 
Director of Head & Neck Oncology, Vice Chair at @WinshipAtEmory. Medical Oncologist; H&N cancer expert. Opinions=my own https://t.co/CXZsMJ6Sg2